This week, the former CEO of the Vancouver biotech company CytoDyn was found guilty of deceiving investors and making a tidy profit from the resulting hoopla after promoting an untested medication as a revolutionary cure for HIV and COVID-19.
Nader Pourhassan, the CEO of CytoDyn until 2022, had come under fire for his unrelenting advocacy of the medication leronlimab. Pourhassen had promised the public and investors for years that it could cure a variety of illnesses, including HIV, several types of cancer, and later COVID-19.
Note: Every piece of content is rigorously reviewed by our team of experienced writers and editors to ensure its accuracy. Our writers use credible sources and adhere to strict fact-checking protocols to verify all claims and data before publication. If an error is identified, we promptly correct it and strive for transparency in all updates, feel free to reach out to us via email. We appreciate your trust and support!
